SPS
ITOS

Susquehanna Portfolio Strategies’s iTeos Therapeutics ITOS Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-204,708
Closed -$2.04M – 1079
2025
Q2 		$2.04M Buy
+204,708
New +$1.65M 0.04% 367
2024
Q4 		– Sell
-62,062
Closed -$634K – 173
2024
Q3 		$634K Sell
62,062
-39,713
-39% -$606K 0.04% 231
2024
Q2 		$1.51M Hold
101,775
– – 0.06% 241
2024
Q1 		$1.39M Sell
101,775
-1,345
-1% -$14.7K 0.03% 397
2023
Q4 		$1.13M Buy
+103,120
New +$1.02M 0.02% 567

Other funds holding ITOS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Susquehanna Portfolio Strategies's ITOS Position: Q3 2025 in Review

Susquehanna Portfolio Strategies sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 204,708 shares — an estimated $2.04M sold.

Susquehanna Portfolio Strategies first reported a position in ITOS in Q4 2023 and held it in 5 quarters. The position peaked at $2.04M in Q2 2025. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.

  • Susquehanna Portfolio Strategies reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Susquehanna Portfolio Strategies sold 204,708 iTeos Therapeutics shares in Q3 2025, an estimated $2.04M.
  • Susquehanna Portfolio Strategies first reported a position in iTeos Therapeutics in Q4 2023 and held it in 5 quarters.
  • Susquehanna Portfolio Strategies's iTeos Therapeutics position peaked at $2.04M in Q2 2025.
  • 1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.

Based on Susquehanna Portfolio Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.